CNSX:RQB

Ravenquest Biomed Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Ravenquest Biomed (CNSX:RQB) Vs. THCX, GLH, ACG, HC, BIO, and BBM

Should you be buying RQB stock or one of its competitors? Companies in the industry of "drug manufacturers - specialty & generic" are considered alternatives and competitors to Ravenquest Biomed, including (THCX.V) (THCX), 31444 (GLH), 438280 (ACG), 815446 (HC), Bio-Rad Laboratories (BIO), and Blueberries Medical (BBM).

Ravenquest Biomed (CNSX:RQB) and (THCX.V) (CVE:THCX) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation and analyst recommendations.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Ravenquest Biomed and (THCX.V), as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ravenquest Biomed0000N/A
(THCX.V)0000N/A

Profitability

This table compares Ravenquest Biomed and (THCX.V)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ravenquest BiomedN/AN/AN/A
(THCX.V)N/AN/AN/A

Valuation & Earnings

This table compares Ravenquest Biomed and (THCX.V)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ravenquest BiomedN/AN/AN/AN/AN/A
(THCX.V)N/AN/AN/AN/AN/A

Ravenquest Biomed (CNSX:RQB) and 31444 (CNSX:GLH) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation and analyst recommendations.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Ravenquest Biomed and 31444, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ravenquest Biomed0000N/A
314440000N/A

Profitability

This table compares Ravenquest Biomed and 31444's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ravenquest BiomedN/AN/AN/A
31444N/AN/AN/A

Valuation & Earnings

This table compares Ravenquest Biomed and 31444's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ravenquest BiomedN/AN/AN/AN/AN/A
31444N/AN/AN/AN/AN/A

Ravenquest Biomed (CNSX:RQB) and 438280 (CNSX:ACG) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation and analyst recommendations.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Ravenquest Biomed and 438280, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ravenquest Biomed0000N/A
4382800000N/A

Profitability

This table compares Ravenquest Biomed and 438280's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ravenquest BiomedN/AN/AN/A
438280N/AN/AN/A

Valuation & Earnings

This table compares Ravenquest Biomed and 438280's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ravenquest BiomedN/AN/AN/AN/AN/A
438280N/AN/AN/AN/AN/A

Ravenquest Biomed (CNSX:RQB) and 815446 (CNSX:HC) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation and analyst recommendations.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Ravenquest Biomed and 815446, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ravenquest Biomed0000N/A
8154460000N/A

Profitability

This table compares Ravenquest Biomed and 815446's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ravenquest BiomedN/AN/AN/A
815446N/AN/AN/A

Valuation & Earnings

This table compares Ravenquest Biomed and 815446's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ravenquest BiomedN/AN/AN/AN/AN/A
815446N/AN/AN/AN/AN/A

Ravenquest Biomed (CNSX:RQB) and Bio-Rad Laboratories (CNSX:BIO) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation and analyst recommendations.

Valuation & Earnings

This table compares Ravenquest Biomed and Bio-Rad Laboratories' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ravenquest BiomedN/AN/AN/AN/AN/A
Bio-Rad LaboratoriesN/AN/AN/AN/AN/A

Profitability

This table compares Ravenquest Biomed and Bio-Rad Laboratories' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ravenquest BiomedN/AN/AN/A
Bio-Rad LaboratoriesN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and target prices for Ravenquest Biomed and Bio-Rad Laboratories, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ravenquest Biomed0000N/A
Bio-Rad Laboratories0000N/A

Ravenquest Biomed (CNSX:RQB) and Blueberries Medical (CNSX:BBM) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership and analyst recommendations.

Valuation and Earnings

This table compares Ravenquest Biomed and Blueberries Medical's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ravenquest BiomedN/AN/AN/AN/AN/A
Blueberries MedicalN/AN/AN/AN/AN/A

Profitability

This table compares Ravenquest Biomed and Blueberries Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ravenquest BiomedN/AN/AN/A
Blueberries MedicalN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and price targets for Ravenquest Biomed and Blueberries Medical, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ravenquest Biomed0000N/A
Blueberries Medical0000N/A


Ravenquest Biomed Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
THCX
(THCX.V)
0.6$5.30flatC$0.00N/A0.00High Trading Volume
News Coverage
GLH
31444
0.4N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
ACG
438280
0.6N/AN/AC$0.00N/A0.00Gap Down
HC
815446
0.5N/AN/A$0.00N/A0.00Gap Down
BIO
Bio-Rad Laboratories
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
BBM
Blueberries Medical
0.6N/AN/A$0.00N/A0.00High Trading Volume
LOVE
Cannara Biotech
0.7N/AN/A$0.00N/A0.00High Trading Volume
CALI
China Auto Logistics
1.3N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
MJ
ETFMG Alternative Harvest ETF
0.5N/AN/A$0.00N/A0.00News Coverage
Gap Down
BOSS
Global X Founder-Run Companies ETF
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
LHS
Liberty Health Sciences
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
LIB
Liberty Leaf
0.5N/AN/AC$0.00N/A0.00High Trading Volume
Gap Down
MMEN
Medmen Enterprises
0.6N/AN/A$0.00N/A0.00High Trading Volume
TGIF
SoFi Weekly Income ETF
0.6N/AN/A$0.00N/A0.00High Trading Volume
Valeant Pharmaceuticals International logo
VRX
Valeant Pharmaceuticals International
0.5N/AN/AC$0.00N/A0.00
VRT
Vertiv
0.5N/AN/A$0.00N/A0.00Gap Down
This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.